Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001130637-25-000005
Filing Date
2025-11-17
Accepted
2025-11-17 16:30:07
Documents
1
Period of Report
2025-11-13

Document Format Files

Seq Description Document Type Size
1 form4-11172025_041103.html 4  
1 form4-11172025_041103.xml 4 6105
  Complete submission text file 0001130637-25-000005.txt   7653
Mailing Address C/O ELEVEN BIOTHERAPEUTICS 215 FIRST ST. #400 CAMBRIDGE MA 02142
Business Address
HURLY STEPHEN A (Reporting) CIK: 0001130637 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40241 | Film No.: 251491408

Mailing Address YALELAAN 62 UTRECHT Netherlands
Business Address YALELAAN 62 UTRECHT Netherlands 31 6 3000 3035
LAVA Therapeutics NV (Issuer) CIK: 0001840748 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)